Imerys annual shareholders’ equity
2019
2020
2021
2022
2023
2024
2025
Imerys Shareholders’ Equity Growth & History (NK)
Imerys's shareholders’ equity was €2.60B for fiscal 2025.
View full Imerys company overviewImerys annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €2.60B | −€679.9M | −20.72% |
| 2024 | 2024-12-31 | €3.28B | €156.8M | +5.02% |
| 2023 | 2023-12-31 | €3.12B | −€213.9M | −6.41% |
| 2022 | 2022-12-31 | €3.34B | €144.5M | +4.52% |
| 2021 | 2021-12-31 | €3.19B | €291.9M | +10.06% |
| 2020 | 2020-12-31 | €2.90B | −€212.2M | −6.82% |
| 2019 | 2019-12-31 | €3.11B | — | — |
Imerys quarterly shareholders’ equity
Q4.24
Q2.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €2.66B | −€430.7M | −13.93% |
| Q4 2025 | 2025-12-31 | €2.60B | −€679.9M | −20.72% |
| Q2 2025 | 2025-06-30 | €3.09B | — | — |
| Q4 2024 | 2024-12-31 | €3.28B | — | — |
Imerys shareholders’ equity trends
Over the last five fiscal years, Imerys's shareholders’ equity decreased from €2.90B to €2.60B, a change of −€300.6M. The latest reported quarter, Q2 2026, shows €2.66B.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company official filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Imerys source filings ↗Community posts
Imerys raises its annual earnings target after margin improvement
Imerys ($NK) increased its 2026 adjusted EBITDA forecast to €570–590 million from €550–580 million after third-quarter adjusted EBITDA rose 14.5% as reported to €160 million. Revenue reached €884 million, up 7.0% as reported and 2.9% at con ...
